Cargando…

Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence

Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, a vast amount of drug research has been conducted and few of them got FDA approval. Our objective is to prioritize repurposable drugs using a pipeline that systematically integrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Kanglin, Wang, Yinyin, Chen, Luyao, Zhao, Zhongming, Savitz, Sean, Jiang, Xiaoqian, Tang, Jing, Kim, Yejin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632883/ https://www.ncbi.nlm.nih.gov/pubmed/34848761 http://dx.doi.org/10.1038/s41598-021-02353-5

Ejemplares similares

Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation
por: Hsieh, Kanglin, et al.
Publicado: (2020)

A computational approach to drug repurposing using graph neural networks
por: Doshi, Siddhant, et al.
Publicado: (2022)

Explainable drug side effect prediction via biologically informed graph neural network
por: Huang, Tongtong, et al.
Publicado: (2023)

DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing
por: Ghorbanali, Zahra, et al.
Publicado: (2023)

An Integrative Heterogeneous Graph Neural Network–Based Method for Multi-Labeled Drug Repurposing
por: Sadeghi, Shaghayegh, et al.
Publicado: (2022)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)

Drug repurposing and prediction of multiple interaction types via graph embedding
por: Amiri Souri, E., et al.
Publicado: (2023)

Counterfactual analysis of differential comorbidity risk factors in Alzheimer’s disease and related dementias
por: Kim, Yejin, et al.
Publicado: (2022)

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network
por: Cui, Chen, et al.
Publicado: (2021)

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers
por: Bang, Dongmin, et al.
Publicado: (2023)

Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks
por: Chipofya, Mapopa, et al.
Publicado: (2021)

GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing
por: Zhang, Fan, et al.
Publicado: (2022)

Drug repurposing for COVID-19 via knowledge graph completion
por: Zhang, Rui, et al.
Publicado: (2021)

Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing
por: Wang, Zichen, et al.
Publicado: (2020)

Task-driven knowledge graph filtering improves prioritizing drugs for repurposing
por: Ratajczak, Florin, et al.
Publicado: (2022)

A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
por: Schultz, Bruce, et al.
Publicado: (2021)

Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks
por: Gravina, Alessio, et al.
Publicado: (2022)

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features
por: Wang, Yinyin, et al.
Publicado: (2022)

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs
por: Feng, Yue-Hua, et al.
Publicado: (2022)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Repurposing Histaminergic Drugs in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2022)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Graph Neural Networks to Advance Anticancer Drug Design
por: Rassil, Asmaa, et al.
Publicado: (2020)

Proteomic meta-study harmonization, mechanotyping and drug repurposing candidate prediction with ProHarMeD
por: Adamowicz, Klaudia, et al.
Publicado: (2023)

Drug-Disease Graph: Predicting Adverse Drug Reaction Signals via Graph Neural Network with Clinical Data
por: Kwak, Heeyoung, et al.
Publicado: (2020)

Reconciling multiple connectivity scores for drug repurposing
por: Samart, Kewalin, et al.
Publicado: (2021)

Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding
por: Islam, Md Kamrul, et al.
Publicado: (2023)

Protein Docking Model Evaluation by Graph Neural Networks
por: Wang, Xiao, et al.
Publicado: (2021)

Drug repositioning based on weighted local information augmented graph neural network
por: Meng, Yajie, et al.
Publicado: (2023)

Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models
por: Jiang, Dejun, et al.
Publicado: (2021)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

The evidence for repurposing anti-epileptic drugs to target cancer
por: Aroosa, Mir, et al.
Publicado: (2023)

Graph Neural Networks and Their Current Applications in Bioinformatics
por: Zhang, Xiao-Meng, et al.
Publicado: (2021)

Introduction to graph neural networks
por: Liu, Zhiyuan, et al.
Publicado: (2020)

A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases
por: Sosa, Daniel N., et al.
Publicado: (2020)

Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph–Based Approach
por: Lou, Pei, et al.
Publicado: (2023)

A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case
por: Huang, Liang-Chin, et al.
Publicado: (2015)

Evaluating graph neural networks under graph sampling scenarios
por: Wei, Qiang, et al.
Publicado: (2022)

Drug-Target Network Study Reveals the Core Target-Protein Interactions of Various COVID-19 Treatments
por: Dai, Yulin, et al.
Publicado: (2022)

SmileGNN: Drug–Drug Interaction Prediction Based on the SMILES and Graph Neural Network
por: Han, Xueting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bf0cj55l28gpfih5kma1gmi8o2